Dexamethasone Dosing in Rheumatoid Arthritis

Introduction to Dexamethasone Dosing

For rheumatoid arthritis management, short-term glucocorticoid therapy with dexamethasone should be tapered as rapidly as clinically feasible, typically within 3 months and only exceptionally by 6 months, with various dose regimens and routes of administration available depending on clinical presentation 1

Short-term glucocorticoids should be considered when initiating or changing conventional synthetic DMARDs (csDMARDs) to bridge the gap until DMARDs take effect, as recommended by the European League Against Rheumatism (EULAR) 1
The European League Against Rheumatism (EULAR) recommends that glucocorticoids should be gradually reduced and ultimately stopped, usually within 3 months from treatment start 1
Long-term use of glucocorticoids, especially at doses above 5 mg/day prednisone equivalent, should be avoided due to potential risks including increased overall and cardiovascular mortality at doses above 7.5 mg/day 1
For RA management, low-dose oral prednisone (7.5-10 mg daily, which would be equivalent to approximately 1.5-2 mg dexamethasone) can effectively control symptoms and may slow radiographic progression 2

Intra-articular corticosteroid injections are recommended as an adjunct to DMARD therapy for patients with one or few residually active joints 2
Triamcinolone hexacetonide appears to be the most effective option for intra-articular injection, but dexamethasone is also an effective alternative 2
Imaging guidance (e.g., ultrasound) may improve accuracy of intra-articular injections 2
Intra-articular injections should be limited to approximately one injection every 6 weeks and no more than 3-4 per year in the same joint 2

Diabetic patients should be informed about the risk of transient increased glycemia following corticosteroid administration 2